Patents Assigned to Companion Diagnostics Inc.
-
Publication number: 20140155282Abstract: Methods of determining stabilization compounds for predictive biomarkers. According to at least one embodiment of a method of the present disclosure, the method comprises introducing a diagnostic marker and a stabilization agent to a detection platform, mixing the diagnostic marker and stabilization agent, and determining their binding characteristics. Additionally, the method may further comprise generating a report based on the binding characteristics and delivering the report to a recipient.Type: ApplicationFiled: June 6, 2013Publication date: June 5, 2014Applicant: Companion Diagnostics, Inc.Inventors: Richard H. Selinfreund, Rakesh Vig, Richard P. Gill
-
Publication number: 20130339752Abstract: A method and apparatus for remotely controlling access to the components of an optically interconnected information processing infrastructure is presented. Access to the infrastructure is controlled independently of the infrastructure operating system.Type: ApplicationFiled: August 13, 2013Publication date: December 19, 2013Applicant: Companion Diagnostics Inc.Inventors: Richard H. SELINFREUND, Fred BERRY
-
Patent number: 8574856Abstract: Methods for determining the efficiency of a therapeutic. In at least one embodiment of a method of determining the efficacy of a therapeutic compound, the method comprises the steps of treating a subject having a disease state with an effective amount of therapeutic compound, harvesting at least one cell from the subject following a treatment with the therapeutic compound, bringing the at least one cell into contact with a stabilizing compound capable of completely or substantially preventing the degradation or inactivation of a diagnostic marker for the disease state, analyzing the at least one stabilized cell for the at least one diagnostic marker, creating a marker profile from at least one result determined from analyzing the at least one stabilized cell, and comparing the marker profile with at least one previous marker profile to determine efficacy of the therapeutic compound on the disease state.Type: GrantFiled: October 18, 2010Date of Patent: November 5, 2013Assignee: Companion Diagnostics Inc.Inventors: Richard H. Selinfreund, Rakesh Vig, Richard P. Gill
-
Patent number: 8501669Abstract: Systems and methods of screening biomarkers in bodily fluids. According to at least one embodiment of the system for analyzing stabilizing agents of the present disclosure, the system comprises a detection platform comprising a plurality of detection sites each capable of receiving a diagnostic marker, a stabilization agent, and a detection agent. The system, in at least one embodiment, further comprises a detection device capable of determining a binding characteristic between the detection agent and the diagnostic marker in the detection sites. Further, the system may also be able to compare the binding characteristic among a plurality of detection markers to order the level of effect of the stabilizing agents assayed on the binding characteristic between the detection agent and the diagnostic agent.Type: GrantFiled: October 18, 2010Date of Patent: August 6, 2013Assignee: Companion Diagnostics Inc.Inventors: Richard H. Selinfreund, Rakesh Vig, Richard P. Gill
-
Publication number: 20130184187Abstract: Systems and methods of biomarker analysis. In at least one embodiment of a system for determining the therapeutic potential of a therapeutic compound the present disclosure, the system comprises a detection platform, a computer database capable of receiving a plurality of binding characteristics, a processor operably coupled to the computer database and the detection platform. In at least one embodiment, the processor has and executes a software program operational to determine a binding characteristic of the detection agent and a stabilized diagnostic agent in each of the plurality of detection sites, compare the binding characteristic among each of the plurality of detection sites, wherein the comparison of binding characteristics is capable of determining the stabilizing agent with the greatest effect on the binding characteristic between the detection agent and the diagnostic agent, generate a binding record using the compared binding characteristics, and deliver the binding record to a recipient.Type: ApplicationFiled: November 27, 2012Publication date: July 18, 2013Applicant: Companion Diagnostics Inc.Inventor: Companion Diagnostics Inc.
-
Publication number: 20130184186Abstract: Systems and methods for the detection of biomarkers. In at least one embodiment of a microarray system of the present disclosure, the microarray system comprises a microarray product comprising at least 100 diagnostic markers/cm2, a microarray identifier, and a stabilizing agent, a control microarray product comprising a first specific binding pair member that binds to a first detectable label, and a processor for providing information regarding the identification and concentration of markers on the microarray based on the identity of the array provided by the microarray identifier.Type: ApplicationFiled: November 27, 2012Publication date: July 18, 2013Applicant: Companion Diagnostics Inc.Inventor: Companion Diagnostics Inc.
-
Publication number: 20130157373Abstract: Systems and methods for hemoglobin analysis. At least one embodiment of a stabilizing system comprises a stabilizing agent useful to completely or substantially prevent degradation or inactivation of a glycosylated hemoglobin (HbA1c) in a body fluid and a detection agent capable of detecting the HbA1c.Type: ApplicationFiled: October 23, 2012Publication date: June 20, 2013Applicant: Companion Diagnostics Inc.Inventor: Companion Diagnostics Inc.
-
Patent number: 8426151Abstract: System and methods for the detection of biomarkers. In at least one embodiment of a system for the detection of a diagnostic marker in a body fluid of the present disclosure, the system comprises a diagnostic device comprising a plurality of test wells, wherein each test well is capable of containing at least one detection agent, a detection device capable of interacting with the diagnostic device, wherein the detection device is capable of detecting an interaction between the at least one detection agent and a diagnostic marker in at least one of the plurality of test wells, and a stabilization agent contained within at least one of the plurality of test wells, the stabilization agent capable of completely or substantially preventing the degradation or inactivation of the detection agent or the diagnostic marker.Type: GrantFiled: October 18, 2010Date of Patent: April 23, 2013Assignee: Companion Diagnostics Inc.Inventors: Richard H. Selinfreund, Rakesh Vig, Richard P. Gill
-
Publication number: 20100254535Abstract: A method and apparatus for remotely controlling access to the components of an optically interconnected information processing infrastructure is presented. Access to the infrastructure is controlled independently of the infrastructure operating system.Type: ApplicationFiled: April 2, 2010Publication date: October 7, 2010Applicant: Companion Diagnostic, Inc.Inventors: Richard H. Selinfreund, Fred Berry